Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest Post author:Sam Post published:November 29, 2017 Post category:BioPharma The round was co-led by Eight Roads Ventures and Cowen Healthcare Investments. Source: BioSpace You Might Also Like Backed by Google, Cambridge's Spero Nabs $51.7 Million Series C March 7, 2017 Chinese Bidders Circle Johnson & Johnson’s $4B+ Diabetes Biz January 16, 2018 This Tiny Massachusetts Biotech Could Reap Big Rewards for Investors October 26, 2017
